Corcept Therapeutics (CORT) FCF Margin (2012 - 2026)
Corcept Therapeutics (CORT) reported FCF Margin of 10.29% for Q1 2026, down 1326.0% on a YoY basis from 0.84% in Q1 2025, and down 154.18% sequentially from 19.0% in Q4 2025.
Corcept Therapeutics (CORT) FCF Margin (2012 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 15 years of FCF Margin data on file, last reported at 10.29% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 1326.0% year-over-year to 10.29%; the trailing twelve-month figure through Mar 2026 stood at 15.62% (down 1021.0% YoY), and the FY2025 full-year result was 18.62%, down 1043.0% from the prior year.
- FCF Margin eased to 10.29% in Q1 2026, from 19.0% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 42.78% in Q3 2023 to a low of 10.29% in Q1 2026.
- A 5-year average of 23.61% and a median of 24.89% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 3085 bps in 2022 and soared 2887 bps in 2024, its largest moves.
- Tracing CORT's FCF Margin over 5 years: stood at 32.37% in 2022, then tumbled by 87 bps to 4.08% in 2023, then jumped by 707 bps to 32.95% in 2024, then plunged by 42 bps to 19.0% in 2025, then tumbled by 154 bps to 10.29% in 2026.
- Business Quant data shows CORT's FCF Margin at 10.29% in Q1 2026, 19.0% in Q4 2025, and 26.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | -10.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.29% |
| Dec 31, 2025 | 19.00% |
| Sep 30, 2025 | 26.24% |
| Jun 30, 2025 | 22.75% |
| Mar 31, 2025 | 2.97% |
| Dec 31, 2024 | 32.95% |
| Sep 30, 2024 | 39.25% |
| Jun 30, 2024 | 24.89% |
| Mar 31, 2024 | 16.18% |
| Dec 31, 2023 | 4.08% |
| Sep 30, 2023 | 42.78% |
| Jun 30, 2023 | 35.84% |
| Mar 31, 2023 | 24.57% |
| Dec 31, 2022 | 32.37% |
| Sep 30, 2022 | 32.73% |
| Jun 30, 2022 | 17.43% |
| Mar 31, 2022 | 37.61% |
| Dec 31, 2021 | 49.95% |
| Sep 30, 2021 | 50.50% |
| Jun 30, 2021 | 48.28% |